id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1977-N-0025-0005,FDA,FDA-1977-N-0025,"Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph, and Related Labeling; Reopening of Comment Period",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2003-06-13T04:00:00Z,2003,6,2003-06-04T04:00:00Z,2003-09-03T03:59:59Z,2019-02-11T13:51:24Z,03-13914,0,0,09000064805da2d9